These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 31377342)

  • 1. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
    Patil SU; Steinbrecher J; Calatroni A; Smith N; Ma A; Ruiter B; Virkud Y; Schneider M; Shreffler WG
    J Allergy Clin Immunol; 2019 Nov; 144(5):1310-1319.e4. PubMed ID: 31377342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy.
    Dreskin SC; Germinaro M; Reinhold D; Chen X; Vickery BP; Kulis M; Burks AW; Negi SS; Braun W; Chambliss JM; Eglite S; McNulty CMG
    Pediatr Allergy Immunol; 2019 Dec; 30(8):817-823. PubMed ID: 31437325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsiveness.
    Orgel K; Burk C; Smeekens J; Suber J; Hardy L; Guo R; Burks AW; Kulis M
    Clin Exp Allergy; 2019 Apr; 49(4):461-470. PubMed ID: 30383313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
    Vickery BP; Scurlock AM; Kulis M; Steele PH; Kamilaris J; Berglund JP; Burk C; Hiegel A; Carlisle S; Christie L; Perry TT; Pesek RD; Sheikh S; Virkud Y; Smith PB; Shamji MH; Durham SR; Jones SM; Burks AW
    J Allergy Clin Immunol; 2014 Feb; 133(2):468-75. PubMed ID: 24361082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE.
    Tsai M; Mukai K; Chinthrajah RS; Nadeau KC; Galli SJ
    J Allergy Clin Immunol; 2020 Mar; 145(3):885-896.e6. PubMed ID: 31805311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing IgG
    Keswani T; LaHood NA; Marini-Rapoport O; Karmakar B; Andrieux L; Reese B; Sneed SL; Pedersen LC; Mueller GA; Patil SU
    J Allergy Clin Immunol; 2024 Jun; 153(6):1611-1620.e7. PubMed ID: 38460677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring Ara h 1, 2 and 3-sIgE and sIgG4 antibodies in peanut allergic children receiving oral rush immunotherapy.
    Nozawa A; Okamoto Y; Movérare R; Borres MP; Kurihara K
    Pediatr Allergy Immunol; 2014 Jun; 25(4):323-8. PubMed ID: 24953293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.
    Thyagarajan A; Jones SM; Calatroni A; Pons L; Kulis M; Woo CS; Kamalakannan M; Vickery BP; Scurlock AM; Wesley Burks A; Shreffler WG
    Clin Exp Allergy; 2012 Aug; 42(8):1197-205. PubMed ID: 22805467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.
    Nagakura KI; Yanagida N; Sato S; Nishino M; Asaumi T; Ogura K; Ebisawa M
    Pediatr Allergy Immunol; 2018 Aug; 29(5):512-518. PubMed ID: 29603410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.
    Wisniewski JA; Commins SP; Agrawal R; Hulse KE; Yu MD; Cronin J; Heymann PW; Pomes A; Platts-Mills TA; Workman L; Woodfolk JA
    Clin Exp Allergy; 2015 Jul; 45(7):1201-13. PubMed ID: 25823600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
    Blumchen K; Beder A; Beschorner J; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Niggemann B; Wahn U; Beyer K
    J Allergy Clin Immunol; 2014 Aug; 134(2):390-8. PubMed ID: 24831438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective.
    Vickery BP; Berglund JP; Burk CM; Fine JP; Kim EH; Kim JI; Keet CA; Kulis M; Orgel KG; Guo R; Steele PH; Virkud YV; Ye P; Wright BL; Wood RA; Burks AW
    J Allergy Clin Immunol; 2017 Jan; 139(1):173-181.e8. PubMed ID: 27522159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IgE and basophil responses to Ara h 2 and Ara h 6 are good predictors of peanut allergy in children.
    van Erp FC; Knol EF; Pontoppidan B; Meijer Y; van der Ent CK; Knulst AC
    J Allergy Clin Immunol; 2017 Jan; 139(1):358-360.e8. PubMed ID: 27516216
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetics of basophil hyporesponsiveness during short-course peanut oral immunotherapy.
    Kulis MD; Smeekens JM; Burk C; Yue X; Guo R; Orgel KA; Ye P; Herlihy L; Hamilton D; Li Q; Keet C; Shreffler W; Vickery BP; Burks AW; Kim EH
    J Allergy Clin Immunol; 2022 Nov; 150(5):1144-1153. PubMed ID: 35716952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2S protein Ara h 7.0201 has unique epitopes compared to other Ara h 7 isoforms and is comparable to 2S proteins Ara h 2 and 6 in basophil degranulation capacity.
    Hayen SM; Ehlers AM; den Hartog Jager CF; Garssen J; Knol EF; Knulst AC; Suer W; Willemsen LEM; Otten HG
    Clin Exp Allergy; 2018 Jul; 48(7):890-897. PubMed ID: 29542223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basophil response to peanut allergens in Mediterranean peanut-allergic patients.
    Mayorga C; Gomez F; Aranda A; Koppelman SJ; Diaz-Perales A; Blanca-López N; Blazquez AB; Blanca M; Torres MJ
    Allergy; 2014 Jul; 69(7):964-8. PubMed ID: 24816395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basophil allergen threshold sensitivity, CD-sens, IgE-sensitization and DBPCFC in peanut-sensitized children.
    Glaumann S; Nopp A; Johansson SG; Rudengren M; Borres MP; Nilsson C
    Allergy; 2012 Feb; 67(2):242-7. PubMed ID: 22126416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.
    Chinthrajah RS; Purington N; Andorf S; Long A; O'Laughlin KL; Lyu SC; Manohar M; Boyd SD; Tibshirani R; Maecker H; Plaut M; Mukai K; Tsai M; Desai M; Galli SJ; Nadeau KC
    Lancet; 2019 Oct; 394(10207):1437-1449. PubMed ID: 31522849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice.
    Kulis M; Chen X; Lew J; Wang Q; Patel OP; Zhuang Y; Murray KS; Duncan MW; Porterfield HS; W Burks A; Dreskin SC
    Clin Exp Allergy; 2012 Feb; 42(2):326-36. PubMed ID: 22288514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of a probiotic with peanut oral immunotherapy: A randomized trial.
    Tang ML; Ponsonby AL; Orsini F; Tey D; Robinson M; Su EL; Licciardi P; Burks W; Donath S
    J Allergy Clin Immunol; 2015 Mar; 135(3):737-44.e8. PubMed ID: 25592987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.